100 related articles for article (PubMed ID: 7838146)
41. Tyrosine 508 of the 85-kilodalton subunit of phosphatidylinositol 3-kinase is phosphorylated by the platelet-derived growth factor receptor.
Kavanaugh WM; Turck CW; Klippel A; Williams LT
Biochemistry; 1994 Sep; 33(36):11046-50. PubMed ID: 8086421
[TBL] [Abstract][Full Text] [Related]
42. The insulin and insulin-like growth factor-I receptor substrate IRS-1 associates with and activates phosphatidylinositol 3-kinase in vitro.
Giorgetti S; Ballotti R; Kowalski-Chauvel A; Tartare S; Van Obberghen E
J Biol Chem; 1993 Apr; 268(10):7358-64. PubMed ID: 8385105
[TBL] [Abstract][Full Text] [Related]
43. Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain.
Antonetti DA; Algenstaedt P; Kahn CR
Mol Cell Biol; 1996 May; 16(5):2195-203. PubMed ID: 8628286
[TBL] [Abstract][Full Text] [Related]
44. Activation of phosphatidylinositol-3 kinase by ligation of the interleukin-7 receptor is dependent on protein tyrosine kinase activity.
Dadi H; Ke S; Roifman CM
Blood; 1994 Sep; 84(5):1579-86. PubMed ID: 7520779
[TBL] [Abstract][Full Text] [Related]
45. Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor.
Gual P; Baron V; Lequoy V; Van Obberghen E
Endocrinology; 1998 Mar; 139(3):884-93. PubMed ID: 9492017
[TBL] [Abstract][Full Text] [Related]
46. Phosphatidylinositol 3-kinase (PI3K) activity bound to insulin-like growth factor-I (IGF-I) receptor, which is continuously sustained by IGF-I stimulation, is required for IGF-I-induced cell proliferation.
Fukushima T; Nakamura Y; Yamanaka D; Shibano T; Chida K; Minami S; Asano T; Hakuno F; Takahashi S
J Biol Chem; 2012 Aug; 287(35):29713-21. PubMed ID: 22767591
[TBL] [Abstract][Full Text] [Related]
47. Phosphatidylinositol 3-kinase activation is mediated by high-affinity interactions between distinct domains within the p110 and p85 subunits.
Holt KH; Olson L; Moye-Rowley WS; Pessin JE
Mol Cell Biol; 1994 Jan; 14(1):42-9. PubMed ID: 8264609
[TBL] [Abstract][Full Text] [Related]
48. Tyrosine kinase activity of a chimeric insulin-like-growth-factor-1 receptor containing the insulin receptor C-terminal domain. Comparison with the tyrosine kinase activities of the insulin and insulin-like-growth-factor-1 receptors using a cell-free system.
Mothe I; Tartare S; Kowalski-Chauvel A; Kaliman P; Van Obberghen E; Ballotti R
Eur J Biochem; 1995 Mar; 228(3):842-8. PubMed ID: 7737184
[TBL] [Abstract][Full Text] [Related]
49. Deficient tyrosine phosphorylation of c-Cbl and associated proteins in phorbol ester-resistant EL4 mouse thymoma cells.
Luo X; Sando JJ
J Biol Chem; 1997 May; 272(18):12221-8. PubMed ID: 9115297
[TBL] [Abstract][Full Text] [Related]
50. Identification of an IGF-1R kinase regulatory phosphatase using the fission yeast Schizosaccharomyces pombe and a GFP tagged IGF-1R in mammalian cells.
Buckley DA; Loughran G; Murphy G; Fennelly C; O'Connor R
Mol Pathol; 2002 Feb; 55(1):46-54. PubMed ID: 11836447
[TBL] [Abstract][Full Text] [Related]
51. Comparison of calcium-dependent conformational changes in the N-terminal SH2 domains of p85 and GAP defines distinct properties for SH2 domains.
Mahadevan D; Thanki N; McPhie P; Beeler JF; Yu JC; Wlodawer A; Heidaran MA
Biochemistry; 1994 Jan; 33(3):746-54. PubMed ID: 8292602
[TBL] [Abstract][Full Text] [Related]
52. Insulin-like growth factor-1 potentiates platelet activation via the IRS/PI3Kalpha pathway.
Hers I
Blood; 2007 Dec; 110(13):4243-52. PubMed ID: 17827393
[TBL] [Abstract][Full Text] [Related]
53. Phosphoinositide 3-kinase binds constitutively to alpha/beta-tubulin and binds to gamma-tubulin in response to insulin.
Kapeller R; Toker A; Cantley LC; Carpenter CL
J Biol Chem; 1995 Oct; 270(43):25985-91. PubMed ID: 7592789
[TBL] [Abstract][Full Text] [Related]
54. Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3'-kinase SH2 domains: a model for SH2-mediated receptor-target interactions.
Reedijk M; Liu X; van der Geer P; Letwin K; Waterfield MD; Hunter T; Pawson T
EMBO J; 1992 Apr; 11(4):1365-72. PubMed ID: 1314163
[TBL] [Abstract][Full Text] [Related]
55. A divalent metal ion binding site in the kinase insert domain of the alpha-platelet-derived growth factor receptor regulates its association with SH2 domains.
Mahadevan D; Thanki N; Aroca P; McPhie P; Yu JC; Beeler J; Santos E; Wlodawer A; Heidaran MA
Biochemistry; 1995 Feb; 34(7):2095-106. PubMed ID: 7857921
[TBL] [Abstract][Full Text] [Related]
56. Structure of 85 kDa subunit of human phosphatidylinositol 3-kinase analyzed by using monoclonal antibodies.
Tanaka S; Matsuda M; Nagata S; Kurata T; Nagashima K; Shizawa Y; Fukui Y
Jpn J Cancer Res; 1993 Mar; 84(3):279-89. PubMed ID: 7683636
[TBL] [Abstract][Full Text] [Related]
57. Direct association of p110 beta phosphatidylinositol 3-kinase with p85 is mediated by an N-terminal fragment of p110 beta.
Hu P; Schlessinger J
Mol Cell Biol; 1994 Apr; 14(4):2577-83. PubMed ID: 8139559
[TBL] [Abstract][Full Text] [Related]
58. Insulin-like growth factor I receptor activated by a transmembrane mutation.
Takahashi K; Yonezawa K; Nishimoto I
J Biol Chem; 1995 Aug; 270(32):19041-5. PubMed ID: 7642566
[TBL] [Abstract][Full Text] [Related]
59. Direct activation of the phosphatidylinositol 3'-kinase by the insulin receptor.
Van Horn DJ; Myers MG; Backer JM
J Biol Chem; 1994 Jan; 269(1):29-32. PubMed ID: 8276809
[TBL] [Abstract][Full Text] [Related]
60. Association of the p85 regulatory subunit of phosphatidylinositol 3-kinase with an essential erythropoietin receptor subdomain.
He TC; Zhuang H; Jiang N; Waterfield MD; Wojchowski DM
Blood; 1993 Dec; 82(12):3530-8. PubMed ID: 7505116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
